Published on

Medicine – Neutropenia

Neutropenia is a haematological condition characterised by a reduction in the absolute neutrophil count (ANC), generally below 1.5 × 10⁹/L in adults.

Neutrophils are essential components of the innate immune system and provide defence against bacterial and fungal infections.

The most important clinical consequence of neutropenia is an increased susceptibility to infection, particularly when the neutrophil count falls below 0.5 × 10⁹/L.

Important Clinical Principle

Neutropenia may result from reduced bone marrow production, increased peripheral destruction, or splenic sequestration and redistribution. Severe neutropenia associated with fever is a medical emergency.

1. Classification of Neutropenia

Severity Absolute Neutrophil Count
Mild1.0–1.5 × 10⁹/L
Moderate0.5–<1.0 × 10⁹/L
Severe0.1–<0.5 × 10⁹/L
ProfoundBelow 0.1 × 10⁹/L

The risk of serious infection increases with the severity and duration of neutropenia, particularly when bone marrow function is impaired.

Reference intervals can vary with age and ancestry. Some otherwise healthy individuals have lower baseline neutrophil counts without increased infection risk, including those with Duffy-null-associated neutrophil counts.

2. Pathophysiology

Neutropenia develops through three principal mechanisms:

  1. Reduced bone marrow production: Inadequate formation of neutrophils.
  2. Increased peripheral destruction: Immune-mediated or drug-associated destruction.
  3. Increased sequestration or redistribution: Particularly associated with hypersplenism and some acute infections.
Neutropenia Reduced Production Chemotherapy Marrow disease B12 / folate deficiency Increased Destruction Autoimmune Drug reactions SLE Sequestration Hypersplenism Splenomegaly Redistribution Reduced Circulating Neutrophils

3. Causes of Neutropenia

A. Viral Infections

Viral infections are among the most common causes of transient acquired neutropenia.

Neutropenia may develop through transient suppression of granulopoiesis, immune-mediated destruction or redistribution of neutrophils.

Examples

  • Influenza and other respiratory viral infections.
  • Epstein–Barr virus (EBV).
  • Cytomegalovirus (CMV).
  • HIV.
  • Hepatitis viruses.
  • Parvovirus B19.
Characteristic Feature: Neutropenia associated with an acute viral illness is frequently transient and resolves as the infection improves, although some infections may cause prolonged neutropenia.

B. Idiosyncratic Drug Reactions

Certain drugs may cause severe neutropenia or agranulocytosis through immune-mediated destruction or toxic effects on granulocyte precursors.

Drug Clinical Significance
CarbimazoleImportant cause of potentially life-threatening agranulocytosis
PropylthiouracilAntithyroid drug-associated agranulocytosis
ClozapineRequires structured ANC monitoring
Co-trimoxazoleMay cause drug-induced neutropenia
SulfasalazineCan suppress granulocyte production
Certain antiepilepticsRare idiosyncratic neutropenia
Some antibioticsMay cause neutropenia, particularly with prolonged exposure

Carbimazole-Induced Agranulocytosis

Carbimazole, used in the treatment of hyperthyroidism, can rarely cause severe neutropenia or agranulocytosis.

Important Warning Symptoms

  • Fever.
  • Sore throat.
  • Mouth ulcers.
  • Signs of infection.
Important Clinical Warning

A patient taking carbimazole who develops fever, sore throat or mouth ulcers should stop carbimazole immediately and seek urgent medical assessment for a full blood count because of the risk of agranulocytosis. Treatment should not be restarted unless specifically directed by an appropriate specialist.

C. Postchemotherapy or Radiotherapy

Cytotoxic chemotherapy damages rapidly dividing bone marrow progenitor cells, reducing neutrophil production.

Radiotherapy involving significant amounts of active bone marrow may produce a similar effect.

Clinical Features

  • Predictable neutrophil suppression after certain chemotherapy regimens.
  • Increased susceptibility to bacterial and fungal infections.
  • Risk of febrile neutropenia.
  • Possible accompanying anaemia and thrombocytopenia.

The neutrophil nadir commonly occurs approximately 7–14 days after many chemotherapy regimens, although the timing varies substantially by treatment.

D. Collagen Vascular Diseases

Autoimmune connective tissue disorders may cause neutropenia through immune-mediated destruction, altered granulopoiesis or splenic sequestration.

1. Systemic Lupus Erythematosus (SLE)

SLE may cause neutropenia through autoimmune mechanisms.

Associated Findings

  • Malar or photosensitive rash.
  • Arthritis.
  • Renal involvement.
  • Other cytopenias, including autoimmune haemolytic anaemia and thrombocytopenia.

2. Rheumatoid Arthritis – Felty's Syndrome

Felty's syndrome is classically characterised by the triad of:

Rheumatoid Arthritis + Splenomegaly + Neutropenia Felty's Syndrome

Felty's syndrome usually occurs in patients with longstanding seropositive rheumatoid arthritis.

Clinical Manifestations

  • Recurrent infections.
  • Leg ulcers.
  • Splenomegaly.
  • Other extra-articular manifestations of rheumatoid arthritis.

Not every patient exhibits all three classical findings.

Examination Pearl: Longstanding rheumatoid arthritis with neutropenia and splenomegaly strongly suggests Felty's syndrome. T-cell large granular lymphocytic leukaemia is an important differential diagnosis.

E. Bone Marrow Infiltration

Bone marrow infiltration can suppress normal granulocyte production.

Important Causes

  • Acute leukaemia.
  • Lymphoma.
  • Multiple myeloma.
  • Metastatic carcinoma.
  • Myelofibrosis.

Neutropenia may occur alongside anaemia and thrombocytopenia, resulting in pancytopenia.

A peripheral blood film may show blasts, immature granulocytes, nucleated red blood cells or other abnormalities depending on the underlying disease.

F. Vitamin B12 or Folate Deficiency

Vitamin B12 and folate are essential for DNA synthesis.

Deficiency causes ineffective haematopoiesis and may produce neutropenia, especially when severe.

Typical Findings

  • Macrocytic anaemia.
  • Macro-ovalocytes.
  • Hypersegmented neutrophils.
  • Thrombocytopenia in severe cases.
  • Possible pancytopenia.

Neurological manifestations may occur with vitamin B12 deficiency.

G. Autoimmune Neutropenia

Autoimmune neutropenia results from antibodies directed against neutrophil antigens, causing increased peripheral destruction.

It may be:

  • Primary: Particularly recognised in infants and young children.
  • Secondary: Associated with autoimmune diseases, lymphoproliferative disorders or other immune conditions.

Primary autoimmune neutropenia of childhood often resolves spontaneously over time.

Treatment depends on infection history, severity and the underlying cause.

H. Hypersplenism

Hypersplenism causes increased sequestration and removal of circulating blood cells, including neutrophils.

Associated Conditions

  • Liver cirrhosis.
  • Portal hypertension.
  • Haematological malignancies.
  • Chronic infections.
  • Infiltrative splenic disorders.

Splenomegaly may be present.

Neutropenia is often accompanied by thrombocytopenia or anaemia.

4. Clinical Features

The clinical manifestations of neutropenia are primarily related to infection.

Clinical Feature Significance
FeverMay indicate serious infection
Sore throatPharyngitis or infection
Mouth ulcersMay occur with severe neutropenia
GingivitisOral infection
Recurrent bacterial infectionsImpaired neutrophil defence
Skin infectionsCellulitis or abscesses
PneumoniaPotential serious infection
SepsisLife-threatening complication
Perianal painPossible perianal infection

Inflammatory signs may be reduced in profound neutropenia because neutrophils are required for a typical pus-forming response.

Consequently, serious infection may occur with relatively subtle local signs.

5. Febrile Neutropenia

Febrile neutropenia is a medical emergency, particularly in patients receiving cytotoxic chemotherapy.

Commonly Used Definition

  • A single oral temperature of at least 38.3°C, or a sustained temperature of at least 38.0°C for one hour.
  • ANC below 0.5 × 10⁹/L, or expected to fall below this threshold.

Definitions may vary between clinical guidelines.

Initial Management

  1. Urgent clinical assessment and evaluation for sepsis.
  2. Full blood count, renal function and other relevant investigations.
  3. Blood cultures and additional microbiological specimens when appropriate.
  4. Prompt empirical broad-spectrum intravenous antibiotics according to local neutropenic sepsis protocols.
  5. Intravenous fluids and organ support when clinically indicated.
  6. Assessment of the need for hospital admission and specialist management.
Medical Emergency

Antibiotics should not be delayed while awaiting laboratory confirmation or culture results in a patient with suspected neutropenic sepsis.

6. Investigations

A. Full Blood Count and Differential

The full blood count confirms neutropenia and determines its severity.

Absolute Neutrophil Count (ANC)

ANC = Total WBC × (% Neutrophils + % Bands) / 100

The white cell count and ANC must use consistent units.

B. Peripheral Blood Film

Blood Film Finding Possible Diagnosis
Isolated neutropeniaViral, drug-induced or autoimmune cause
BlastsAcute leukaemia
Macro-ovalocytes and hypersegmented neutrophilsMegaloblastic anaemia
Dysplastic neutrophilsMyelodysplastic neoplasm
Leucoerythroblastic pictureMarrow infiltration or fibrosis
Multiple cytopeniasMarrow failure, nutritional deficiency or hypersplenism

C. Additional Investigations

Depending on the clinical presentation:

  • Vitamin B12 and folate.
  • Liver and renal function tests.
  • Viral investigations, including HIV when indicated.
  • Autoimmune tests such as ANA and rheumatoid factor.
  • Blood cultures when infection is suspected.
  • Medication review.
  • Bone marrow aspiration and trephine biopsy when persistent unexplained neutropenia or marrow disease is suspected.

7. Diagnostic Approach

ANC <1.5 × 10⁹/L Confirm severity and duration Fever or Severe Infection? Urgent treatment if suspected History and Blood Film Drugs, infections, autoimmune disease Other cytopenias or splenomegaly Targeted Investigations B12, folate, viral and immune tests Marrow examination if indicated Identify Underlying Cause Cause-specific management

8. Management

Management depends on the underlying cause, severity of neutropenia and whether infection is present.

Cause General Management
Viral infectionSupportive care and monitoring; treat specific infections when indicated
Drug-induced neutropeniaPrompt withdrawal of the suspected causative drug
Chemotherapy-inducedMonitoring, infection management and G-CSF in selected patients
SLETreatment of underlying autoimmune disease
Felty's syndromeRheumatoid arthritis-directed treatment and specialist care
Bone marrow infiltrationTreatment of the underlying malignancy
Vitamin B12 deficiencyVitamin B12 replacement
Folate deficiencyFolate replacement after appropriate B12 assessment
Autoimmune neutropeniaObservation or immune-directed treatment in selected cases
HypersplenismTreatment of the underlying condition

Granulocyte Colony-Stimulating Factor (G-CSF)

G-CSF, such as filgrastim, stimulates neutrophil production in the bone marrow.

Possible Indications

  • Prevention of chemotherapy-associated febrile neutropenia in selected high-risk patients.
  • Selected cases of established chemotherapy-associated neutropenia.
  • Severe chronic neutropenia with recurrent infections.
  • Certain cases of severe drug-induced agranulocytosis under specialist guidance.

G-CSF is not routinely required for every patient with neutropenia.

9. High-Yield Examination Summary

Cause Key Association
Viral infectionsCommon cause of transient neutropenia
CarbimazoleIdiosyncratic agranulocytosis
ChemotherapySuppression of granulopoiesis
RadiotherapyMarrow suppression
SLEAutoimmune neutrophil destruction
Felty's syndromeRA, splenomegaly and neutropenia
Marrow infiltrationMay cause pancytopenia
Vitamin B12 / folate deficiencyMegaloblastic changes
Autoimmune neutropeniaAntineutrophil antibodies may be involved
HypersplenismIncreased splenic sequestration

10. Key Examination Pearls

  • Neutropenia is generally defined as ANC below 1.5 × 10⁹/L.
  • Severe neutropenia is ANC below 0.5 × 10⁹/L.
  • Viral infections commonly cause transient neutropenia.
  • Carbimazole may cause life-threatening agranulocytosis.
  • Chemotherapy-induced neutropenia increases the risk of bacterial and fungal infections.
  • Felty's syndrome is associated with rheumatoid arthritis, splenomegaly and neutropenia.
  • Vitamin B12 and folate deficiency may produce neutropenia with macrocytic anaemia.
  • Bone marrow infiltration often causes abnormalities in multiple blood cell lines.
  • Hypersplenism may cause neutropenia with thrombocytopenia.
  • Febrile neutropenia requires urgent assessment and prompt empirical antimicrobial treatment.
Most Important Examination Point

Neutropenia with fever in a patient receiving chemotherapy suggests febrile neutropenia; neutropenia with fever or sore throat in a patient taking carbimazole suggests drug-induced agranulocytosis; and neutropenia with longstanding rheumatoid arthritis and splenomegaly suggests Felty's syndrome.

Clinical Warning

Fever or suspected infection in a patient with severe neutropenia requires urgent medical assessment. Neutropenic sepsis can progress rapidly even when local signs of infection are minimal.

Kembara Xtra – Medicine Revision Notes

Image description
0 Comments